The role of sacubitril/valsartan in the management of cardiac resynchronization therapy non‐responders: a retrospective analysis

The role of sacubitril/valsartan in the management of cardiac resynchronization therapy non‐responders: a retrospective analysis

Abstract Aims Optimal medical therapy after cardiac resynchronization therapy (CRT) implantation is important in heart failure (HF) with reduced ejection fraction (HFrEF) patients. Although sacubitril/valsartan (SV) is a mainstay in the treatment of HFrEF, its efficacy in the management of CRT non‐r...

Full description

Bibliographic Details
Main Authors: Kyeong‐Hyeon Chun, Jaewon Oh, Hee Tae Yu, Chan Joo Lee, Tae‐Hoon Kim, Jae Sun Uhm, Hui‐Nam Pak, Moon‐Hyoung Lee, Boyoung Joung, Seok‐Min Kang
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:ESC Heart Failure
Subjects:
Cardiac resynchronization therapy
Heart failure with reduced ejection fraction
Sacubitril/valsartan
Online Access:https://doi.org/10.1002/ehf2.12988

Internet

https://doi.org/10.1002/ehf2.12988

Similar Items